Long-term patient-reported outcomes from an open-label safety and efficacy study of bosutinib in Philadelphia chromosome–positive chronic myeloid leukemia patients resistant or intolerant to prior therapy

Hagop M. Kantarjian, Carla M. Mamolo, Carlo Gambacorti-Passerini, Jorge E. Cortes, Tim H. Brümmendorf, Yun Su, Arlene L. Reisman, Mark Shapiro, Jeff H. Lipton

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term patient-reported outcomes from an open-label safety and efficacy study of bosutinib in Philadelphia chromosome–positive chronic myeloid leukemia patients resistant or intolerant to prior therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences